Studies suggest that millions of men fall victim to Prostate Cancer. Different types of Prostate Cancer include Adenocarcinoma, neuroendocrine tumors, prostate sarcomas, squamous cell carcinomas, small-cell carcinomas, and transitional cell carcinomas.

Adenocarcinoma

This cancer type makes up an extensive majority of the cases of Prostate Cancer. Experts suggest that about 95% of Prostate Cancer cases are Adenocarcinoma. About 9 out of 10 adenocarcinoma cancers are acinar while the minimal fraction is ductal. Acinar Adenocarcinoma originates in the acini cells and enhances the prostate-specific antigen (PSA) levels. The cancer cells additionally produce fluid-secreting glands and clusters. Ductal Adenocarcinoma originates in the cells of the prostate gland’s ducts and does not necessarily affect PSA levels. Ductal Adenocarcinoma is thus difficult to detect and can spread rapidly compared to acinar Adenocarcinoma.

Neuroendocrine Tumors

Neuroendocrine tumors are often called carcinoids. Located in the neuroendocrine system, these tumors start developing slowly. The neuroendocrine system consists of glands and nerve cells that play an imperative role in producing and transferring the hormones in the bloodstream. Neuroendocrine tumors originate in the digestive system, thereby spreading to other places like the prostate. These cancers occur rarely and do not have an impact on prostate-specific antigen levels. NETS are hereditary in nature and are responsible for secreting hormones. The symptoms of this type of Prostate Cancer are irregular heartbeat, wheezing, diarrhea, dizziness, skin flushing, and Fatigue.

Prostate sarcomas

Sarcomas are the rarest type of Prostate Cancer and contribute to about 0.1% of the total cases of Prostate Cancer. This cancer originates In the soft tissues that comprise nerves and muscles. Soft tissues are located all over the human body. Sarcomas can spread everywhere in the body. The commonly affected regions of the sarcomas are in the lungs. Sarcomas tend to break, thereby spreading in different regions of the body. The commonly known prostate sarcomas are rhabdomyosarcoma and leiomyosarcomas. These cancers usually affect men aged 35 to 60. Studies have reported that very minimal cases have been detected in children. These sarcomas can be extremely difficult to detect and do not impact the PSA levels.

Squamous cell carcinoma

Squamous cell carcinoma is an advanced, rare, but rapidly spreading Prostate Cancer. Cancer, in-line other prostate cancers do not originate in the gland cells. It is initiated in the flat cells of the prostate glands. Squamous cell carcinoma is an aggressive type of prostate carcinoma cancer and can effectively spread to different parts of the body.

Small Cell carcinoma

Small cell carcinoma is directly linked to neuroendocrine cancer and is a rare type of Prostate Cancer. These cancers are aggressive and do not affect the levels of PSA. About 1% of the total number of prostate cancers are small cell carcinoma. In most cases, small cell carcinoma is metastasized before its detection. Most cases cannot utilize basic treatments such as Hormone therapy because the cancer is too advanced. Due to the poor prognosis of this cancer, the estimated life expectancy of the patients is less than a year.

Transitional cell carcinoma

Transitional cell carcinoma or urothelial cancer originates from the prostate structures and the urethra’s cell lining. Prostate Cancer can usually grow as the fundamental tumors in the bladder and the urethra. The tumors break after which they start spreading rapidly to different body parts. Transitional cell carcinoma usually initiates with blood in the urine. This cancer type is rare and advanced due to which enhanced treatment is vitally required.